Projects per year
Personal profile
Education
- 2007 Ph.D., Molecular and Cellular Toxicology, North Carolina State University
- 2002 MEM, Nicholas School of the Environment and Earth Sciences, Duke University
- 1998 BS, Atomic Science, National Tsing-Hua Unversity
Experience
- 2019.01-2019.12 Chief, International Research, Office of Global Engagement, Taipei Medical University
- 2019- Associate Professor, Graduate Institute of Cancer Biology and Drug Discovery, Taipei Medical University
- 2019- Associate Professor, Ph.D. Program for Cancer Molecular Biology and Drug Discovery, Taipei Medical University
- 2019- Associate Professor, Ph.D. Program in Biotechnology Research and Development, Taipei Medical University
- 2018-2019 Assistant Professor, Ph.D. Program in Biotechnology Resaerch and Development, Taipei Medical University
- 2018-2019 Assistant Professor, Ph.D Program for Cancer Molecular Biology and Drug Discovery Taipei Medical University
- 2013-2019 Assistant, Professor, Ph.D Program for Cancer Molecular Biology and Drug Discovery, Taipei Medical University
- 2010-2011 PharmaEssentia Corp. Senior Scientist
- 2007-2010 University of Pennsylvania, Postdoctoral fellow
Research Interests
- Cancer Biology
- Signal Transduction
- Molecular Toxicology
Fingerprint
- 1 Similar Profiles
Network
-
高效率掺銩鎖模光纖雷射放大器與其在生醫材料加工之應用
1/1/23 → 12/31/23
Project: C - Project of Alliance › j - National Taipei University of Technology
-
The Drug Discovery and Pharmacological Role for Novel Dyrk1b Inhibitors in Pancreatic Cancer (1/3)
8/1/22 → 7/31/23
Project: A - Government Institution › b - Ministry of Science and Technology
-
新穎性DYRK1B 抑制劑之體外生物活性評估
1/1/22 → 12/31/22
Project: B - Project of TMU › h - Higher Education Sprout Project
-
新穎性DYRK1A抑制劑於阿茲海默症之機轉探討(3/3)
8/1/21 → 7/31/22
Project: A - Government Institution › b - Ministry of Science and Technology
-
探討利用類黃酮作為新穎DYRK1B抑制劑在惡性胰臟癌之療效
7/1/21 → 2/28/22
Project: A - Government Institution › b - Ministry of Science and Technology
-
Correction: Chondroitin sulfate proteoglycan 4 regulates zebrafish body axis organization via Wnt/planar cell polarity pathway (PLoS ONE (2020) 15:4 (e0230943) DOI: 10.1371/journal.pone.0230943)
Lee, Y. H., Kawakami, K., HuangFu, W. C. & Liu, I. H., Jun 2022, In: PLoS ONE. 17, 6 June, e0270539.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Identification and analysis of a selective DYRK1A inhibitor
Lin, T. E., Chao, M. W., HuangFu, W. C., Tu, H. J., Peng, Z. X., Su, C. J., Sung, T. Y., Hsieh, J. H., Lee, C. C., Yang, C. R., Pan, S. L. & Hsu, K. C., Feb 2022, In: Biomedicine and Pharmacotherapy. 146, 112580.Research output: Contribution to journal › Article › peer-review
Open Access3 Citations (Scopus) -
Identification of a dual FLT3 and MNK2 inhibitor for acute myeloid leukemia treatment using a structure-based virtual screening approach
Yen, S. C., Chen, L. C., Huang, H. L., HuangFu, W. C., Chen, Y. Y., Eight Lin, T., Lien, S. T., Tseng, H. J., Sung, T. Y., Hsieh, J. H., Huang, W. J., Pan, S. L. & Hsu, K. C., Apr 2022, In: Bioorganic Chemistry. 121, p. 105675 105675.Research output: Contribution to journal › Article › peer-review
Open Access6 Citations (Scopus) -
O-methylated flavonol as a multi-kinase inhibitor of leukemogenic kinases exhibits a potential treatment for acute myeloid leukemia
Yen, S. C., Wu, Y. W., Huang, C. C., Chao, M. W., Tu, H. J., Chen, L. C., Lin, T. E., Sung, T. Y., Tseng, H. J., Chu, J. C., Huang, W. J., Yang, C. R., HuangFu, W. C., Pan, S. L. & Hsu, K. C., Jun 2022, In: Phytomedicine. 100, 154061.Research output: Contribution to journal › Article › peer-review
Open Access5 Citations (Scopus) -
A novel dual HDAC and HSP90 inhibitor, MPT0G449, downregulates oncogenic pathways in human acute leukemia in vitro and in vivo
Wu, Y. W., Chao, M. W., Tu, H. J., Chen, L. C., Hsu, K. C., Liou, J. P., Yang, C. R., Yen, S. C., HuangFu, W. C. & Pan, S. L., May 2021, In: Oncogenesis. 10, 5, 39.Research output: Contribution to journal › Article › peer-review
Open Access11 Citations (Scopus)
Datasets
-
Additional file 1 of Investigating the potential effects of selective histone deacetylase 6 inhibitor ACY1215 on infarct size in rats with cardiac ischemia-reperfusion injury
Pan, S. (Contributor), Hsu, K. (Creator), Lin, T. E. (Creator), Lin, C. (Creator), Huang, H. (Contributor) & HuangFu, W. (Contributor), Figshare, 2020
DOI: 10.6084/m9.figshare.11992497.v1, https://doi.org/10.6084%2Fm9.figshare.11992497.v1
Dataset
-
Identification of a dual TAOK1 and MAP4K5 inhibitor using a structure-based virtual screening approach
Chao, M. (Creator), Lin, T. E. (Creator), HuangFu, W. (Creator), Chang, C. (Creator), Tu, H. (Creator), Chen, L. (Creator), Yen, S. (Creator), Sung, T. (Creator), Huang, W. (Creator), Yang, C. (Creator), Pan, S. (Creator) & Hsu, K. (Creator), Taylor & Francis, 2020
DOI: 10.6084/m9.figshare.13213424.v1, https://tandf.figshare.com/articles/dataset/Identification_of_a_dual_TAOK1_and_MAP4K5_inhibitor_using_a_structure-based_virtual_screening_approach/13213424/1
Dataset
-
Investigating the potential effects of selective histone deacetylase 6 inhibitor ACY1215 on infarct size in rats with cardiac ischemia-reperfusion injury
Lin, C. (Creator), Hsu, K. (Creator), HuangFu, W. (Contributor), Lin, T. E. (Creator), Huang, H. (Contributor) & Pan, S. (Contributor), Figshare, 2020
DOI: 10.6084/m9.figshare.c.4896705.v1, https://springernature.figshare.com/collections/Investigating_the_potential_effects_of_selective_histone_deacetylase_6_inhibitor_ACY1215_on_infarct_size_in_rats_with_cardiac_ischemia-reperfusion_injury/4896705/1
Dataset
-
EGFL6 promotes colorectal cancer cell growth and mobility and the anti‐cancer property of anti-EGFL6 antibody
Sung, T. (Creator), Huang, H. (Contributor), Cheng, C. (Creator), Chang, F. (Creator), Wei, P. (Contributor), Cheng, Y. (Creator), Huang, C. (Contributor), Lee, Y. (Contributor), HuangFu, W. (Creator) & Pan, S. (Creator), Figshare, 2021
DOI: 10.6084/m9.figshare.c.5341486.v1, https://springernature.figshare.com/collections/EGFL6_promotes_colorectal_cancer_cell_growth_and_mobility_and_the_anti_cancer_property_of_anti-EGFL6_antibody/5341486/1
Dataset
-
Additional file 3 of EGFL6 promotes colorectal cancer cell growth and mobility and the anti‐cancer property of anti-EGFL6 antibody
HuangFu, W. (Creator), Sung, T. (Creator), Lee, Y. (Contributor), Pan, S. (Creator), Cheng, Y. (Creator), Chang, F. (Creator), Wei, P. (Contributor), Huang, C. (Contributor), Huang, H. (Contributor) & Cheng, C. (Creator), Figshare, 2021
DOI: 10.6084/m9.figshare.14228284.v1, https://doi.org/10.6084%2Fm9.figshare.14228284.v1
Dataset